A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma
Clinical trial NCT01464112 · COMPLETED
Trial details
- NCT number
- NCT01464112
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-16
- Primary completion
- 2013-11-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.